Published on Monday September 06, 2021
We are working on the following new projects:
- We are preparing a contract for a phase 1 clinical trial with Dalteparin sodium.
- Our company signed a contract signature for the observational program with a top ten pharma.
We are happy to reach the following milestones in our projects:
- We received the Council of Ethics approval in the trial with COVID-19 vaccine.
- The enrollment was finished in the Spasmoanalgesic trial.
- The screening was performed in the Ibuprofen trial.